Naturally they claim they can stop it by suing to halt compounding and also say it could lead to malpractice claims if not using the FDA approved product. The latter being pretty lame, considering how would anyone prove the compounded didn't work and the sngx would have?
Still don't get how they get SNGX out of Soligenix. A bit of a nitpick from me.
they requested the symbol sgnx but nasdaq screwed up the symbol.
Doesn't it follow that the commercial upside is limited given this practice as well?
the product compounded in the formularies is the immediate release pills. They also have an extended release pill that extends the treatment to the area lower down in the gut. That treats the entire gi system.
Market Data 
Markets 
AI
